Valuation : Abbott Laboratories

Market Cap 191B 164B 154B 141B 265B 18,170B 267B 1,829B 712B 9,214B 717B 701B 30,508B P/E 2026 *
31.7x
P/E 2027 * 24.4x
Enterprise Value 215B 185B 174B 159B 298B 20,448B 300B 2,059B 801B 10,369B 807B 789B 34,332B EV / Sales 2026 *
4.27x
EV / Sales 2027 * 3.88x
Free-Float
86.16%
Yield 2026 *
2.33%
Yield 2027 * 2.48%
1 day-0.91%
1 week-5.67%
Current month-0.74%
1 month+2.26%
3 months+24.79%
6 months-4.01%
Current year-12.57%
1 week 109.48
Extreme 109.48
116.72
1 month 104.2
Extreme 104.2
117.34
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap. Importance
8/25/26 Exercice

Chief Executive Officer

1,196,496 0.0691%
8/12/26 Other

EXECUTIVE VICE PRESIDENT

-12 0.0000% -
6/30/26 Free

Director

416 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.93%-5.67%-16.67%+6.50% 191B
+0.56%-0.23%-2.57%+10.71% 116B
+1.82%+0.43%+11.75%+88.32% 61.75B
+0.09%-0.58%+0.28%-32.25% 51.24B
+1.18%-0.02%+29.30%+54.07% 51.51B
-0.53%+1.69%+22.03%-11.02% 34.36B
+1.26%+0.41% - - 30.73B
-0.37%-2.12%+39.93%-16.34% 24.01B
+1.13%-1.96%-4.47%+15.32% 23.23B
-1.44%-2.76%-5.00%-0.42% 22.68B
Average +0.26%-1.49%+8.29%+12.77% 60.65B
Weighted average by Cap. +0.10%-1.94%+0.46%+15.02%

Financials

2026 *2027 *
Net sales 50.3B 43.31B 40.67B 37.12B 69.74B 4,786B 70.24B 482B 187B 2,427B 189B 185B 8,036B 54.65B 47.05B 44.18B 40.33B 75.76B 5,199B 76.3B 524B 204B 2,637B 205B 201B 8,730B
Net income 6.23B 5.37B 5.04B 4.6B 8.64B 593B 8.7B 59.71B 23.23B 301B 23.4B 22.89B 996B 7.92B 6.82B 6.41B 5.85B 10.99B 754B 11.06B 75.92B 29.54B 382B 29.75B 29.11B 1,266B
Net Debt 23.94B 20.61B 19.35B 17.67B 33.19B 2,278B 33.43B 229B 89.23B 1,155B 89.88B 87.93B 3,824B 20.96B 18.04B 16.94B 15.47B 29.05B 1,994B 29.26B 201B 78.11B 1,011B 78.69B 76.98B 3,348B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-09-01 US$109.48 -0.80% 1,820,013
26-08-31 US$110.36 -1.88% 10,691,544
26-08-28 US$112.47 +0.79% 7,545,562
26-08-27 US$111.59 -2.20% 8,355,172
26-08-26 US$114.10 -1.75% 6,959,229
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
110.36USD
Average target price
120.20USD
Spread / Average Target
+8.92%

Quarterly revenue - Rate of surprise